Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | LLY | REGN |
|---|
| Close | 1,152.44 | 789.45 |
| Market Cap | $1.07T | $79.7B |
| 1M | −5.98% | −2.57% |
| P/E (TTM) | 39.9 | 18.5 |
| Forward P/E | 28.5 | 14.1 |
| P/E 5-Yr Percentile | 6 | 48 |
| P/S | 13.4 | 5.2 |
| P/B | 31.5 | 2.5 |
| Dividend Yield | 0.75% | 0.47% |
| Latest Quarter Revenue | $23.0B | $4.3B |
| Revenue YoY | +47.7% | +16.7% |
| Gross Margin | 85.8% | — |
| Latest Quarter EPS | 7.94 | 12.23 |
| Avg Post-Earnings Move | ±3.5% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | 4.61% |
| 90-Day Net Insider Buying | −$16.0M | −$3.4M |
LLY · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
